Jefferies analyst Glen Santangelo raised the firm’s price target on Accolade to $12 from $10 and keeps a Hold rating on the shares after updating the firm’s estimates to incorporate Q3 results and updated management commentary. While “encouraged” by better than expected results in the quarter, the firm remains “somewhat cautious” that the operating environment could be a near-term headwind, the analyst tells investors.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ACCD:
- A New Cause for Concern: Accolade, Inc. Adds a New Regulation Risk
- Accolade price target raised to $16 from $15 at Truist
- Accolade price target raised to $15 from $12 at Piper Sandler
- Accolade price target raised to $12 from $10 at Wells Fargo
- Accolade backs FY25 revenue view up 20%, consensus $493.01M
